Emerging skin biotech Position B.A.I. Biosciences as a cutting-edge dermatology partner with a portfolio of over 20 patented technologies focusing on atopic dermatitis, skin cancer prevention, and anti-aging. Target mid-market dermatology clinics, cosmetic brands, and contract research organizations seeking novel preventative skincare solutions.

Pavise suncare catalyst Leverage the March 2023 Pavise launch as a lead magnet for partnerships in suncare and preventative dermatology. Propose co-development, licensing, or distribution deals with skincare brands and retailers aiming to expand suncare innovation portfolios.

Growing revenue signals With reported revenue in the mid seven-figure range and a relatively small team, emphasize high-growth, capital-efficient collaboration opportunities such as white-label formulations, joint ventures, or strategic research collaborations to scale sales without massive upfront investment.

Tech-enabled capabilities Highlight cloud-based infrastructure and collaborative tools (AWS, Google libraries, monday.com, Webflow) as enablers for rapid program management, data sharing, and scalable product development. Offer services around digital project management, regulatory documentation support, and vendor integrations to streamline partnerships.

Strategic fit with big players Position as a complementary biotech partner to larger contract research and life sciences companies (e.g., firms with extensive lab networks and cosmetic/dermatology portfolios). Target potential collaborations, licensing, or acquisition conversations with mid-to-large players looking to augment their dermatology pipelines.